Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 and BA.5 subvariant predominance: a systematic literature review

Myriam Drysdale, Mehmet Berktas, Daniel C. Gibbons, Catherine Rolland, Louis Lavoie, Emily J. Lloyd
doi: https://doi.org/10.1101/2023.12.04.23299370
Back to top
Posted December 04, 2023.
Download PDF

Supplementary Material

Email
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 and BA.5 subvariant predominance: a systematic literature review
Myriam Drysdale, Mehmet Berktas, Daniel C. Gibbons, Catherine Rolland, Louis Lavoie, Emily J. Lloyd
medRxiv 2023.12.04.23299370; doi: https://doi.org/10.1101/2023.12.04.23299370
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area